These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1810217)

  • 21. Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.
    Peters GJ; Van Dijk J; Nadal JC; Van Groeningen CJ; Lankelma J; Pinedo HM
    In Vivo; 1987; 1(2):113-7. PubMed ID: 2979771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan).
    Giovanella BC; Stehlin JS; Hinz HR; Kozielski AJ; Harris NJ; Vardeman DM
    Int J Oncol; 2002 Jan; 20(1):81-8. PubMed ID: 11743646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and evaluation of anticancer agents.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1988 Feb; 10(2):67-101. PubMed ID: 3283480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. About the possibilities of registration of drug influence by means of radiocardiographic function analysis.
    Lösel E; Kleine N; Hoffmann G
    Nuklearmedizin; 1981 Oct; 20(5):236-40. PubMed ID: 7031609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
    Mladosievicova B; Carter A; Kristova V
    Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of preclinical toxicology studies for platinum anticancer drugs.
    Clark DL; Andrews PA; Smith DD; DeGeorge JJ; Justice RL; Beitz JG
    Clin Cancer Res; 1999 May; 5(5):1161-7. PubMed ID: 10353752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of 5-FU action by thymidine in murine and human tumors.
    Young CW; Woodcock TM; Martin DS
    Cancer Treat Rep; 1981; 65 Suppl 3():83-7. PubMed ID: 7346156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer chronotherapy: is there a right time in the day to treat?
    Hrushesky WJ
    J Infus Chemother; 1995; 5(1):38-43. PubMed ID: 7634176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil.
    Schwartz PM; Dunigan JM; Marsh JC; Handschumacher RE
    Cancer Res; 1980 Jun; 40(6):1885-9. PubMed ID: 7371020
    [No Abstract]   [Full Text] [Related]  

  • 30. Modification of radiosensitivity by the so-called tissue recovery stimulator. I. Radiosensitizing effects of solcoseryl.
    Kumar A; Kimura H; Aoyama T; Sugahara T
    J Radiat Res; 1992 Dec; 33(4):282-9. PubMed ID: 1293298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (1) Preparation of an animal model for continuous intra-arterial infusion and comparison of the therapeutic and adverse effects of 5-fluorouracil delivered by various modes].
    Ota J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2353-61. PubMed ID: 6639097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of age on antileukemic action, subacute toxicity and tissue distribution of ambazone in B6D2F1 mice.
    Amlacher R; Baumgart J; Härtl A; Weber H; Kühnel HJ; Schulze W; Hoffmann H
    Arch Geschwulstforsch; 1990; 60(1):11-8. PubMed ID: 2310296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of "Solcoseryl" during culture on the sex-dependent repair of bovine demi-embryos.
    Tominaga K; Yoneda K; Utsumi K
    Mol Reprod Dev; 1996 Mar; 43(3):331-5. PubMed ID: 8868246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer chronotherapy: a drug delivery challenge.
    Hrushesky WJ
    Prog Clin Biol Res; 1990; 341A():1-10. PubMed ID: 2145583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of solcoseryl and vincristine on the mechanical strength of the femur shaft in young rats.
    Nadulska A; Klukowska L; Dyba S
    Ann Univ Mariae Curie Sklodowska Med; 2000; 55():189-92. PubMed ID: 11482071
    [No Abstract]   [Full Text] [Related]  

  • 36. Grouping of anticancer drugs based on administration method-related toxicity patterns in rats.
    Mizushima Y; Li H; Sassa K; Fujishita T; Oosaki R; Kobayashi M
    Anticancer Res; 1997; 17(6D):4611-4. PubMed ID: 9494577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice.
    Elliott WL; Howard CT; Dykes DJ; Leopold WR
    Cancer Res; 1989 Oct; 49(20):5586-90. PubMed ID: 2477146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration].
    Fujita F; Fujita M; Inaba H; Taguchi T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):223-8. PubMed ID: 8434959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Solcoseryl: Ulcerostatic effect and possible mechanisms].
    Rasulov MM; Kuznetsov IG; Slutskiĭ LI; Zabozlaev AG; Voronkov MG
    Biull Eksp Biol Med; 1993 Jan; 115(1):49-51. PubMed ID: 7519901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].
    Shirasaka T; Taguchi T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.